• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER; INTERVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER; INTERVASCULAR CATHETER Back to Search Results
Catalog Number 382544
Device Problems Degraded (1153); Device Packaging Compromised (2916)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/22/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(6).A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that the seal on a bd insyte¿ autoguard¿ shielded iv catheter appears degraded, packets opening spontaneously therefore no longer sterile.No injury or medical intervention.
 
Manufacturer Narrative
H.6.Investigation summary: device/batch history record review findings: the lot number was built on afa line 9 from nov 21, 2016 thru nov 23, 2017 and packaged on packaging line 11 from nov 26, 2016 to nov 27, 2016.Per review it was noted that there were no reject activity findings throughout the build of this lot that would impact upon the quality of the product.The peura (end user risk analysis) was analyzed to determine the risk to customer.The analysis showed that current risk is acceptable.Occurrence and severity rankings have not changed.Observations and testing: received 1 insyte autoguard bc 18ga unit from lot number 6321514.Exp.2019-10-31.Visual/microscopic examination: the package received revealed the top web (paper) was slightly lifted from the bottom web (clear) but the seal integrity was not compromised note: the product characteristics require a minimum of 1/8¿ seal width with adhesive transfer from the top web paper to the bottom web film.Conclusions: even though the package received revealed the top web (paper) was slightly lifted from the bottom web (clear) but the seal integrity was not compromised.Although the defect experienced by the customer was not confirmed with this particular incident, the failure is a known issue and was investigated under capa 48637.Capa 48637 was initiated to address the issue of open seal complaints.Tasks associated with the capa plan have been completed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER
Type of Device
INTERVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
MDR Report Key7613497
MDR Text Key111917370
Report Number1710034-2018-00301
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier30382903825449
UDI-Public30382903825449
Combination Product (y/n)N
PMA/PMN Number
K110443
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 06/26/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date10/31/2019
Device Catalogue Number382544
Device Lot Number6321514
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/04/2018
Initial Date Manufacturer Received 05/25/2018
Initial Date FDA Received06/19/2018
Supplement Dates Manufacturer Received05/25/2018
Supplement Dates FDA Received06/26/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-